Docket Number:28A-960119
Inventor:Chi-Huey Wong, David Ho, Alice Yu, Rachel TJ Cheng, Ming Wei Chen, Yaoxing Huang
IP Status:US pending、PCT pending、TW pending
Abstract:
The team led by Dr. David Ho of Rockefeller University and Dr. Chi-Huey Wong of the Genomics Research Center of Academia Sinica in Taiwan has reported a DNA-based vaccine candidate for avian flu which shows promise in mice. This work has paved a way for developing effective preventive medicine to avoid the globally dreaded possible pandemic.
It is known that a type of glycoprotein molecule called Hemagglutinin (HA) found on the surface of the H5N1 virus is used by the virus to infect host cells in the first step of its attack. The team obtained HA from various H5N1 strains and did the analysis of the genome. As a result, they designed an artificial HA gene that represents a common sequence of HA from all reported H5N1 strains and named it "Consensus HA". The "Consensus HA" DNA sequence was then inserted into a circular piece of DNA for replication in E. coli and became the H5N1 DNA vaccine.
Then, mice immunized with the H5N1 DNA vaccine were exposed to different strains of the avian flu virus, including the Vietnam, Indonesia, Turkey, and Anhui strain, since these viruses represent most current avian flu cases throughout the world.
The result was very promising; it showed that 80% of the mice survive from the high-dose challenge by the Indonesia type virus and 100% of the mice survive from the challenge by any one of the other three types, while all the mice without immunization die after the challenge. Antibodies as well as cellular immune responses have been detected in these mice.
While flu viruses will continue to mutate rapidly, this vaccine strategy could provide a fast, affordable, and easily modifiable approach to combat avian flu.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
